Author's reply: "Anti-parietal cell antibodies are more prevalent and clinically relevant in autoimmune endocrine diseases: Comment on the ARIOSO position paper" [0.03%]
作者回复：“抗壁细胞抗体在自身免疫性内分泌疾病中更常见且具有临床意义：对ARIOSO立场文件的评论」
Edith Lahner,Marco Vincenzo Lenti,Sara Massironi et al.
Edith Lahner et al.
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the Liver [0.03%]
意大利肝病研究协会的人工智能立场文件
Clara Balsano,Anna Alisi,Patrizia Burra et al.
Clara Balsano et al.
Artificial Intelligence (AI) is transforming medicine, providing unprecedented opportunities to enhance diagnosis, prognosis, and treatment across all areas of hepatology. This Position Paper by the Italian Association for the Study of the ...
Inflammatory vs. complicated Crohn's disease: Long-term outcomes after ileocecal resection [0.03%]
炎症性与并发症性的克罗恩病患者回肠切除术的长期预后分析
Mukesh Kumar,Payal Kumari,Sangeeta Davi et al.
Mukesh Kumar et al.
Author's reply: "ERCP for pediatric chronic pancreatitis: PEP prophylaxis and multidimensional outcome assessment deserve greater attention" [0.03%]
作者答复：儿童慢性胰腺炎的ERCP：预防PEP和多维结果评估值得关注
Simona Faraci,Giovanni Rollo,Luigi Dall&#x;Oglio et al.
Simona Faraci et al.
Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives [0.03%]
液态活检在胰腺癌中的应用：当前进展、局限性及未来前景
Silvia Carrara,Michele Bevere,Donatella Delle Cave et al.
Silvia Carrara et al.
Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic malignancy and is usually diagnosed at advanced stages. The diagnosis of PDAC is established through pancreatic cytology/tissue biopsy, most commonly obtained under endos...
AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update [0.03%]
日本肝病治疗指南（2026年更新版）：代谢功能紊乱相关脂肪性肝病和脂肪性肝炎的药物治疗
Associazione Italiana per lo Studio del Fegato (AISF)
Associazione Italiana per lo Studio del Fegato (AISF)
Metabolic dysfunction-associated steatotic liver disease (MASLD) has rapidly emerged as the leading cause of chronic liver disease worldwide, gradually replacing viral hepatitis in clinical and epidemiological relevance. Italian data mirror...
Focal lesions in the cirrhotic liver: an update on LI-RADS classification and clinical implications [0.03%]
肝硬化肝脏局灶性病变的最新LI-RADS分类及临床意义
Antonino Andrea Blandino,Federica Vernuccio,Roberto Cannella et al.
Antonino Andrea Blandino et al.
Hepatocellular carcinoma (HCC) is a major global health burden, and imaging is crucial for its detection, characterization, and post-treatment assessment. The Liver Imaging Reporting and Data System (LI-RADS) was developed to standardize te...
Practical management of glucagon-like peptide-1 receptor agonists in gastroenterology: a position paper by the Italian Society of Gastroenterology (SIGE) [0.03%]
意大利胃肠病学会(SIGE)关于肠促胰素类似物在胃肠病学中实际应用的立场文件
Antonio Facciorusso,Edoardo G Giannini,Matteo Tacelli et al.
Antonio Facciorusso et al.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for type 2 diabetes and obesity, conditions frequently encountered in gastroenterological practice. Their pleiotropic effects along the gut-pancreas-liver axis...
Toward precision chemotherapy in pancreatic ductal adenocarcinoma: molecular, transcriptomic and clinical determinants [0.03%]
精准化疗胰腺导管腺癌：分子、转录组和临床决定因素
Gabriele Capurso,Ingrid Garajova,Cindy Neuzillet et al.
Gabriele Capurso et al.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, with chemotherapy remaining the backbone of systemic treatment across disease stages. Although multi-agent regimens such as modified FOLFIRINOX and gemcitabine ...